NCT02041546

Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome

Zekai Tahir Burak Maternity Teaching Hospital

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
• Sex: All
• Age: 7 Days
• Healthy volunteers: Not accepted

Summary

Meconium aspiration syndrome (MAS) is an important cause of severe respiratory failure in newborn infants. Treatment for MAS is mainly supportive but surfactant therapy might change the course of the disease. Aim of the study to evaluate whether lung lavage with dilute or bolus poractant alfa changes the duration of mechanical respiratory support or other outcomes in MAS.

Conditions

• Meconium Aspiration Syndrome

Interventions

Type	Name	Description
DRUG	Lung lavage with surfactant
DRUG	Bolus surfactant

Timeline

• Start date: 2013-09-01
• Primary completion: 2014-12-01
• Completion: 2014-12-01
• First posted: 2014-01-22
• Last updated: 2016-08-03

Locations

1 site across 1 country: Turkey (Türkiye)